ArticleNature2021
A long-term perspective on immunity to COVID.
Article in Nature, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Public health authorities in Germany during the SARS-CoV-2 pandemic - a constructive-critical reflection.GMS hygiene and infection control · 2026Article
- Anti-TNF therapy impairs both short- and long-term IgG responses after repeated vaccination.Allergy · 2025Article
- COVAX - Time to reconsider the strategy and its target.Health policy OPEN · 2023Article
- Delay-differential SEIR modeling for improved modelling of infection dynamics.Scientific reports · 2023Article
- Pathways to Immunity: Patterns of Excess Death Across the United States and Within Closed Religious Communities.Journal of religion and health · 2023Article
- Donor selection for adoptive cell therapy with CD45RACytotherapy · 2023Article
- Impedimetric Nanobiosensor for the Detection of SARS-CoV-2 Antigens and Antibodies.ACS sensors · 2023Article
- Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection.Journal of travel medicine · 2022Article
- SARS-CoV-2-The Role of Natural Immunity: A Narrative Review.Journal of clinical medicine · 2022Review
- Epidemiological model based periodic intervention policies for COVID-19 mitigation in the United Kingdom.Scientific reports · 2022Article
- Article
- Article
- Blood and saliva SARS-CoV-2 antibody levels in self-collected dried spot samples.Medical microbiology and immunology · 2022Article
- Urban monitoring, evaluation and application of COVID-19 listed vaccine effectiveness: a health code blockchain study.BMJ open · 2022Article
- The Russia-Ukraine war could bring catastrophic public-health challenges beyond COVID-19.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022Article
- Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis.Multiple sclerosis (Houndmills, Basingstoke, England) · 2022Article
- Assessment of humoral and cellular immune responses to SARS CoV-2 vaccination (BNT162b2) in immunocompromised renal allograft recipients.Transplant infectious disease : an official journal of the Transplantation Society · 2022Article
- Humoral and Cellular Responses to SARS-CoV-2 in Convalescent COVID-19 Patients With Multiple Sclerosis.Neurology(R) neuroimmunology & neuroinflammation · 2022Article
- Sustained seroprevalence of SARS-CoV-2 antibodies one year after infection: one of the first COVID-19 cluster cases in Bosnia and Herzegovina.Bosnian journal of basic medical sciences · 2022Article
- COVID-19 reinfections among naturally infected and vaccinated individuals.Scientific reports · 2022Article
Corrections and comments
- Comment on
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
34127832What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.